Wednesday, October 4th, 10:00 A.M. - 1:00 P.M.DALLAS, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Joni and Friends, a global non-profit…
ANN ARBOR, MI / ACCESSWIRE / September 13, 2023 / LanguageLine Solutions, the world leader in language access and interpretation…
PARIS, FRANCE / ACCESSWIRE / September 12, 2023 / Ad Scientiam, a global leader in digital biomarkers, has announced a…
CARMEL, Ind., Sept. 12, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology…
New Test Analyzes Highly Curated Set of 236 Genes Most Associated with Autism Spectrum Disorder, Intellectual Disabilities, and Developmental Delay.HOUSTON,…
Leading Swiss oral health brand introduces innovative solution to empower individuals with disabilities to achieve independent oral care MESA, Ariz.,…
TORONTO, ON / ACCESSWIRE / August 29, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage…
Quantum Health’s newly added clinical advisory boards will launch in 2024 to expand the company’s strategic clinical guidance for musculoskeletal…
Fast Track Designation (FTD) is designed to accelerate the development and expedite the review of therapies with potential to address…
CARMEL, Ind., Aug. 22, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS), (“NeurAxis,” or the “Company”), a medical technology…